Found 489 hits.
| 423. | Song, X., Chen, Y.-D., Yu, M., Liu, B., Zhao, Z. T.+, and Maurer, M.+: Omalizumab in children and adolescents with chronic urticaria: a 16 week real-world study. Allergy 2021: 76; 1271-1273. IF: 14.71 |
o.423
|
453. |
Khoshkhui, M., Weller, K., Fadaee, J., Maurer, M., Azad, F. J., and Emadzadeh, M.+: Evaluation of the reliability and validity of the Persian version of urticaria control test (UCT). Iran J. Allergy Asthma Immunol. 2021: 20; 423-431. IF: 1.57 |
o.453
|
582. |
Demir, S.+, Eyice-Karabacak, D., Kocatürk, E., Ünal, D., Toprak, İ. D., Korkmaz, P., Aslan, A. F., İmren, I. G., Dikicier, B., Kahveci, N., Öztop, N., Kara, R. Ö., İşsever, H., Maurer, M., Weller, K., and Gelincik, A.: Monitoring recurrent angioedema: findings from the Turkish angioedea control test validation study. Clin. Transl. Allergy 2024: 14; e12342. IF: TBD (IF 2023: 4.60) |
o.582
|
599. |
Mak, H. W. F., Lee, E., Wong, J. C. Y. Weller, K., Maurer, M., and Li, P. H.+: Validity, reliability, and sensitivity of change of the traditional Chinese urticaria control test (UCT) in Hong Kong. J. Allergy Clin. Immunol. Glob. 2024: 3; 100290. IF: N/A |
o.599
| 89 | Metz, M., Scholz, E., Ferrán, M., Izquierdo, I., Giménez-Arnau, A., and Maurer, M.+: Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria. Ann. Allergy Asthma Immunol. 2010: 104; 86-92. IF: 2.80 |
| 305 | Kikuchi, A., Inami, A., Nasir, F. B. M., Mohsen, A., Watanuki, S., Miyake, M., Matsuda, R., Koike, D., Ito, T., Sasakawa, J., Takeda, K., Hiraoka, K., Maurer, M. Yanai, K., Watabe, H., and Tashiro, M.+: Effects of levocetirizine and diphenhydramine on regional glucose metabolic changes and hemodynamic responses in the human prefrontal cortex during cognitive tasks. Hum. Psychopharmacol. Clin. Exp. 2018: 33; e2655. IF: 2.26 |
| 152 | Maurer, M. Rosén, K.+, Hsie, H. J., Saini, S., Grattan, C., Gimenéz-Arnau, A., Agarwal, S., Doyle, R., Canvin, J., Kaplan, A., and Casale, T.: Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. New Engl. J. Med. 2013: 368; 924-935. IF: 54.40 |
| 101. | Mitchell, S., Balp, M. M., Samuel, M., McBride, D., and Maurer, M.: Systematic review of treatments for chronic spontaneous urticaria with inadequate response to licensed first-line treatments. Int. J. Dermatol. 2015: 54; 1088-1104. IF: 1.41 |
r.101
| 231 | Potter, P., Mitha, E., Barkai, L., Gyorgyl, M., Santamaria, E., Izquierdo, I.+, and Maurer, M.: Rupatadine is effective in the treatment of chronic spontaneous urticaria in children aged 2-11 years. Pediatr. Allergy Immunol. 2016: 27; 55-61. IF: 3.77 |
| 90. | Mullol, J., Bousquet, J., Bachert, C., Canonica, G. W., Giménez-Arnau, A., Kowalski, M. L., Simons, F. E. R., Maurer, M., Ryan, D., and Scadding, G.: Update on rupatadine in the management of allergic disorders. Allergy 2015: 70: 1-24. IF: 6.33 |